09.15 Registration and Coffee

10.00 Welcome and Introduction

10.05               KEYNOTE LECTURE

                   Increasing productivity in drug discovery

                   Dr Peter Goodfellow (GlaxoSmithKline)

                       [Abstract]

10.50              Computer modelling of cell systems for target selection and therapy design

                        Professor David Fell (Oxford Brookes University)

                       [Abstract] [PowerPoint]

11.20 Coffee

11.50              Computational approaches in formulation development

                        Dr Robert Docherty (Pfizer)

                       [Abstract] [PDF]

12.20              In-silico screening without structural comparisons: Real Lead Hopping

                        Dr Andy Vinter (Cresset BioMolecular Discovery)

                       [Abstract] [PDF]

12.50 Lunch

13.50              Chemists are from Venus, modellers are from Mars

                        Dr Michael Bodkin (Eli Lilly)

                       [Abstract] [Powerpoint]

14.20              The development of local and global QSAR models to predict ADMET properties

                        Dr Andrew M Davis (AstraZeneca)

14.50 Tea

15.15              Successes and pitfalls in the data mining of HTS data

                        Dr Stephen Pickett (GlaxoSmithKline)

                       [Abstract] [PDF]

15.45              A rapid visualisation of bioavailability potential using simple radar plots

                       Dr Tim Ritchie (Novartis)

                       [Abstract] [Powerpoint]

16.15              De novo design algorithms:  where we are now and where we will be in two years time?

                        Dr Philip Dean (De Novo Pharmaceuticals)

                       [Abstract] [PDF]

16.45              Close